Abacten 200 mg/5 ml (Powder for Suspension)

30 ml bottle: ৳ 130.00

Medicine Details

Title

  • Abacten 200 mg/5 ml Suspension

Categories

  • Antibiotics
  • Medication
  • Pharmaceuticals

Description

  • Indicated for infections in lower respiratory tract
  • Indicated for infections in upper respiratory tract
  • Indicated for otitis media
  • Indicated for skin and soft tissue infections
  • Indicated for sexually transmitted diseases
  • Pharmacologically stable in acidic conditions
  • Readily absorbed
  • Absorption is greater on an empty stomach
  • Active transport to site of infection
  • Large concentrations released during active phagocytosis
  • High concentration in tissues
  • Half-life allows for large single dose administration
  • Bacteriostatic levels maintained for several days
  • Plasma clearance of 630 mL/min
  • Terminal elimination half-life of 68 hours
  • Biliary excretion of azithromycin
  • Active against aerobic and facultative gram-positive microorganisms
  • Active against aerobic and facultative gram-negative microorganisms
  • Active against other microorganisms
  • Binds to the 50S ribosomal subunit of susceptible microorganisms
  • Interferes with microbial protein synthesis
  • Not affecting nucleic acid synthesis
  • Oral dosage for adults: 500 mg once daily for 3 days
  • Oral dosage for children based on body weight
  • Azithromycin injection for adult patient dosage
  • Reconstitution procedure for suspension
  • Caution with concurrent use of antacids
  • Potential pharmacokinetic interaction with carbamazepine
  • Potential pharmacokinetic interaction with cyclosporin
  • Potential impairment of digoxin metabolism
  • Avoid co-administration with ergot derivatives
  • No significant effect on methylprednisolone pharmacokinetics
  • No evidence of theophylline pharmacokinetic interaction
  • No alteration of warfarin anticoagulant effect
  • No significant impact on terfenadine pharmacokinetics
  • Contraindicated in patients hypersensitive to azithromycin
  • Contraindicated in co-administration with ergot derivatives
  • Contraindicated in patients with hepatic diseases
  • Low incidence of side-effects
  • Majority of side-effects gastrointestinal in origin
  • Allergic reactions such as rash or photosensitivity
  • Reversible elevations in liver transaminases
  • Rare cases of cholestatic jaundice observed
  • Hearing impairment in investigational studies
  • Pregnancy category B
  • No evidence of harm to the fetus in animal reproduction studies
  • Caution during pregnancy if adequate alternatives are not available
  • Unknown secretion in breast milk
  • Caution with administration to nursing women
  • Risk of serious allergic reactions
  • Use in renal impairment
  • No dose adjustment needed in patients with mild renal impairment
  • Use not recommended in patients with severe renal impairment
  • Not recommended in patients with hepatic impairment
  • No evidence of effect on patients' ability to drive or operate machinery
  • No data on overdosage with Abacten
  • Typical symptoms of overdosage with macrolide antibiotics
  • No specific data on overdose effects of Abacten
  • Storage in a dry place away from light and heat
  • Chemical structure: Molecular Formula - C38H72N2O12

Related Brands